Related Experiment Video
Updated: Jun 2, 2026

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells
Published on: January 20, 2019
Modulation of the poliovirus receptor expression in malignant lymphocytes by epigenetic alterations
Wei Wang1, Li Gao, Xinrong Wang
1Department of Hematology, Chinese PLA General Hospital, Beijing, China.
Abstract:
Malignant lymphocytes are characterized by their low expression of poliovirus receptor (PVR), ligand for the activating natural killer (NK) cell receptors, which may explain their insensitivity toward NK cell-based therapeutic approaches. Here, we have studied the mechanism of this defective expression of PVR. We demonstrated that the characterization of NK-insensitive cell lines was of low expression of PVR in both mRNA and surface levels, and that PVR of RAJI cells able to resist NK cells has hypermethylated promoter-associated CpG islands. After treating with 5-azacytidine (5-AZA) (ie, hypomethylation agent) and suberoylanilide hydroxamic acid (SAHA) (ie, histone deacetylase inhibitor), respectively or simultaneously, the abnormal epigenetic status became partly reversed, and the mRNA and surface expression of PVR restored. The expression restoration of the gene enhanced susceptibility of RAJI cells to NK cells but, when the RAJI cells were incubated with the specific blocking antibody for PVR's receptor, the enhanced susceptibility would diminish. Patients with acute myeloid leukemia expressed higher PVR than patients with acute lymphoblastic leukemia in both mRNA and surface levels. Epigenetic modulation of hypermethylation and histone deacetylase is involved in repressing PVR expression in malignant lymphocytes resistant to NK cells.
Insights
Malignant lymphocytes resist natural killer (NK) cell therapy due to low poliovirus receptor (PVR) expression. Epigenetic modifications, specifically DNA methylation and histone deacetylase activity, were found to repress PVR, offering therapeutic targets.
Area of Science:
- Immunology
- Cancer Biology
- Epigenetics
Background:
- Malignant lymphocytes often exhibit low poliovirus receptor (PVR) expression, contributing to resistance against natural killer (NK) cell-mediated therapies.
- PVR serves as a ligand for activating NK cell receptors, making its downregulation a critical factor in immune evasion by cancer cells.
Purpose of the Study:
- To investigate the epigenetic mechanisms underlying the defective PVR expression in NK-insensitive malignant lymphocytes.
- To explore the potential of epigenetic modulation to restore PVR expression and enhance NK cell-mediated cytotoxicity.
Main Methods:
- Analysis of PVR mRNA and surface protein levels in NK-sensitive and NK-insensitive cell lines.
- Assessment of PVR promoter-associated CpG island methylation status.
- Treatment of cells with epigenetic modifiers: 5-azacytidine (5-AZA) and suberoylanilide hydroxamic acid (SAHA).
- Evaluation of NK cell-mediated cytotoxicity against treated cells and assessment of PVR blockade effects.
Main Results:
- NK-insensitive cell lines, including RAJI cells, displayed significantly lower PVR expression at both mRNA and surface levels.
- Hypermethylation of PVR promoter-associated CpG islands was observed in NK-resistant RAJI cells.
- Treatment with 5-AZA and SAHA partially reversed epigenetic abnormalities, restoring PVR expression.
- Restored PVR expression on RAJI cells increased their susceptibility to NK cell killing, an effect diminished by PVR-blocking antibodies.
- Patients with acute myeloid leukemia showed higher PVR expression compared to those with acute lymphoblastic leukemia.
Conclusions:
- Epigenetic mechanisms, including DNA hypermethylation and histone deacetylase activity, play a crucial role in repressing PVR expression in malignant lymphocytes resistant to NK cell surveillance.
- Targeting these epigenetic alterations presents a promising strategy to re-sensitize resistant cancer cells to NK cell-based immunotherapy.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Epigenetic Regulation
Abnormal Proliferation
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Poliomyelitis

